Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Versicor (VERS) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (55)	11/17/2003 11:35:17 PM
From: tuck	Read Replies (3) \| Respond to of 83

Hadn't looked here in a while. Interesting to see micafungin might have drug interaction problems; I don't recall seeing that in my diggings (which are here somewhere, but I'm too lazy at the moment to go point to it). I do remember FDA asking for more data on it, allowing MICU to catch up, know we know why. Not sure how much pop there would be from these levels, given that good news is expected on both near term events. But a pullback might be a good buying op. Cheers, Tuck